Hong Kong, China

Hong Xue

USPTO Granted Patents = 9 

Average Co-Inventor Count = 1.5

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Suining, CN (2019)
  • Hong Kong, CN (2003 - 2024)

Company Filing History:


Years Active: 2003-2024

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Hong Xue

Introduction

Hong Xue is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer research, holding a total of 9 patents. His work focuses on innovative methods for detecting and treating cancer, showcasing his commitment to advancing medical science.

Latest Patents

One of Hong Xue's latest patents is titled "Detection and treatment of daughter number variations in cancer cells." This invention provides in vitro methods for predicting a compound's ability to inhibit multinucleate cell production resulting from post-mitotic cell fusion during a process of Daughter Number Variation (DNV) in mitosis. The compounds identified by this method can be utilized in cancer treatment, either alone or in combination with other known cancer drugs. Additionally, the invention offers methods of personalized cancer treatment for patients with malignant tumors.

Another significant patent is "Genome-wide capture of inter-transposable element segments for genomic sequence analysis of human DNA samples with microbial contamination." This method identifies genomic variations in human genomic DNA by employing Alu, MIR, and SVA sequence-based PCR primers. It performs an inter-transposable-element (ITE) polymerase chain reaction on the assay mixture to produce an array of amplicons comprising the ITE genomic segments. The method is also useful for identifying genomic variants associated with specific traits or diseases.

Career Highlights

Throughout his career, Hong Xue has worked with various organizations, including Pharmacogenetics Limited. His innovative research has positioned him as a key figure in the field of pharmacogenetics and cancer treatment.

Collaborations

Hong Xue has collaborated with notable individuals in his field, including Jeffrey Tze-Fei Wong and Hongyan Wang, who is a distinguished female researcher. Their combined efforts have contributed to advancements in cancer research and treatment methodologies.

Conclusion

In summary, Hong Xue is an influential inventor whose work in cancer research has led to significant innovations and advancements. His patents reflect a deep commitment to improving cancer treatment and understanding genomic variations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…